September 26, 2013
Mayo Clinic in the News Weekly Highlights
September 27, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]
Tags: ABC News, ABCnews.com, Affordable care act, Arizona State University, ASU Insight, Batman, blood biomarker, Bob Nellis, Breast Cancer, CDC, Chris Gade, CNBC
March 4, 2013
Dasatinib thwarts brain cancer metastasis after bevacizumab use
Bevacizumab therapy can provide significant but temporary clinical benefit in persons with recurrent glioblastoma, acknowledged Panos Z. Anastasiadis, PhD, chair of the Department of Cancer Biology at Mayo Clinic in Jacksonville, Florida, and colleagues in their report for PLOS One. The drug causes these brain tumors to shrink by depriving them of blood nutrients, but certain proteins […]
Tags: bevacizumab therapy, blood nutrients, brain tumors, cancer cells, Department of Cancer Biology, Dr. Panos Z. Anastasiadis, Glioblastoma, Oncology Nurse Advisor, PLoS One, proteins
February 26, 2013
Research partnership uncovers cancer clues
When it comes to making inroads in the fight against cancer, two heads are better than one…Mayo Clinic molecular biologist Jim Maher, Ph.D., and University of Minnesota medicinal chemist Gunda Georg, Ph.D., led the research, which is published the findings in the journal PLoS ONE…The findings suggest that drugs might work by blocking the yeast […]
Tags: Dr. Gunda Georg, Dr. Jim Maher, KARE 11, PLoS One, University of Minnesota, yeast cells
March 2, 2012
Cell powerhouse might be at root of Alzheimer’s
Mayo Clinic scientists have shown that a tiny part of a cell might be at the root of Alzheimer’s disease development. In a study published in PLoS One Thursday, Mayo neuroscientist Eugenia Trushina, biochemist Petras Dzeja and colleagues report that they determined mitochondrial organelles in the cells of mice became dysfunctional long before the transgenic […]
Tags: Alzheimer's disease development, biochemist, Eugenia Trushina, neuroscientist, Petras Dzeja, PLoS One